Detection of methylated BCAT1 and IKZF1 in stage II/III rectal cancer receiving chemoradiation.

被引：2
|
作者：
Chen, Chin-Tung [1 ]
Tufts, Lauren [1 ]
Aggarwal, Piyush [1 ]
Heller, Frederick [1 ]
Weiser, Martin R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
602
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiation in stage II and III rectal cancer: Analysis of tumor response and toxicity
    Grana, Begona
    Gomez, Antonio
    Vidal, Yolanda
    del Rio, Lorena
    Garcia, Jorge
    Curiel, Teresa
    Candamio, Sonia
    Carballo, Ana
    Peleteiro, Paula
    Lopez, Rafael
    ANNALS OF ONCOLOGY, 2004, 15 : 79 - 79
  • [42] 结肠镜检出结果之非直肠癌患者外周血甲基化BCAT1和IKZF1阳性的影响因素研究
    马志蛟
    李洪现
    张旗
    医药论坛杂志, 2023, 44 (08) : 43 - 47
  • [43] MnSOD and GPx-1 polymorphisms in relation to local recurrence in patients with rectal cancer treated with chemoradiation.
    Gordon, MA
    Zhang, W
    Yang, DY
    Gil, J
    Yun, J
    Press, O
    Mallik, N
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 271S - 271S
  • [44] Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer
    Spigel, David R.
    Bendell, Johanna C.
    McCleod, Michael
    Shipley, Dianna L.
    Arrowsmith, Edward
    Barnes, E. Kirk
    Infante, Jeffrey R.
    Burris, Howard A., III
    Greco, F. Anthony
    Hainsworth, John D.
    CLINICAL COLORECTAL CANCER, 2012, 11 (01) : 45 - 52
  • [45] 血液中SEPT9、IRF4、BCAT1和IKZF1基因甲基化对结直肠癌临床诊断的价值研究
    杨葳
    庄严
    刘鹏飞
    国际生物医学工程杂志, 2020, 43 (02) : 128 - 134
  • [46] Factors Predictive of Receiving Chemoradiation Therapy in Stage II and III Rectosigmoid Cancer and the Impact on Overall Survival
    Scheick, S.
    Lloyd, S.
    Boothe, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E186 - E186
  • [47] Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer:: A phase II study
    Gambacorta, MA
    Valentini, V
    Morganti, AG
    Mantini, G
    Miccichè, F
    Ratto, C
    Di Miceli, D
    Rotondi, F
    Alfieri, S
    Doglietto, GB
    Vargas, JG
    De Paoli, A
    Rossi, C
    Cellini, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : 130 - 138
  • [48] Use of the XRCC1 single nucleotide polymorphism to predict pathologic complete response to neoadjuvant chemoradiation in stage II/III rectal cancer.
    Duldulao, M. P.
    Li, W.
    Ho, J.
    Chen, Z.
    Lee, W.
    Kim, J.
    Garcia-Aguilar, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] The Expression of Claudin-1 is an Effective Indicator of Recurrence and Prognosis in Stage II and Stage III Rectal Cancer
    Yoshida, Takefumi
    Kinugasa, Tetsushi
    Shirouzu, Kazuo
    Akagi, Yoshito
    GASTROENTEROLOGY, 2011, 140 (05) : S344 - S344
  • [50] Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis
    Latkauskas, T.
    Paskauskas, S.
    Dambrauskas, Z.
    Gudaityte, J.
    Saladzinskas, S.
    Tamelis, A.
    Pavalkis, D.
    COLORECTAL DISEASE, 2010, 12 (11) : 1075 - 1083
12345